Xeljanz XR 11 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F97L0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,369
Award facts
- Contract value 100% obligated
- $13,369.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on January 20, 2026, awards $13,369.03 to AmerisourceBergen Drug Corp for the supply of XELJANZ XR 11 MG tablets in quantities of 30 units. The contract is a firm fixed-price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract with the Defense Logistics Agency (DLA) Troop Support Medical valued at $999.99 million through December 2026. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
This task order represents a routine pharmaceutical supply delivery under the DLA's comprehensive global pharmaceutical support program, which enables the distribution of brand-name and generic medications, vaccines, and related medical supplies to support military healthcare operations worldwide. The firm fixed-price structure and non-competitive award mechanism reflect the established relationship under the underlying IDC vehicle. As a critical vendor in the federal pharmaceutical supply chain, AmerisourceBergen fulfills ongoing medical commodity requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with this particular delivery order focused on fulfilling prescription medication needs for military treatment facilities and related federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F97L0?
SPE2DR26F97L0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F97L0 worth?
The government has obligated $13,369 on SPE2DR26F97L0.
Is contract SPE2DR26F97L0 an order under another contract?
Yes. SPE2DR26F97L0 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F97L0 competed?
The extent of competition for SPE2DR26F97L0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award